GlassScriptPhysician profile
Walid Y Saad
NPI 1164752499
$3,425.75
in general payments reported to CMS, 2019-2025
25 companies · $633 in 2025
The $633 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $30.03 · 2021: $824 · 2022: $554 · 2023: $608 · 2024: $530 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,771.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $925.58 | 2021-2025 | Indigo System |
| Boston Scientific Corporation | $626.64 | 2022-2025 | Avvigo Guidance System, Watchman Flx |
| Abbott Laboratories | $373.61 | 2022-2025 | Navitor, Dragonfly Opstar |
| Cook Medical LLC | $159.20 | 2019 | |
| Medtronic, INC. | $153.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $145.28 | 2019-2022 | |
| Amgen INC. | $145.11 | 2023-2025 | Repatha, Repatha |
| Heartflow, INC. | $144.59 | 2023 | Ffrct |
| Shockwave Medical, INC | $120.99 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $102.66 | 2023 | Diamondback Coronary |
| Intuitive Surgical, INC. | $91.75 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.23 | 2019-2022 | |
| Novo Nordisk INC | $67.21 | 2023-2024 | Ozempic, Rybelsus |
| Distalmotion US | $51.77 | 2025 | Dexter L6 Robot |
| Tactile Systems Technology INC | $44.70 | 2024 | Entre Plus, Flexitouch Plus |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $33.81 | 2023-2024 | |
| Abiomed | $30.46 | 2023 | Impella |
| Lantheus Medical Imaging, INC. | $23.74 | 2023 | Definity |
| Kiniksa Pharmaceuticals International, Plc | $20.17 | 2024 | Arcalyst |
| Braemar Manufacturing, LLC | $18.40 | 2019 | |
| Medtronic Vascular, INC. | $18.30 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.10 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.92 | 2023 | |
| Astellas Pharma US INC | $13.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walid Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.